Back to results
US 11,633,475 B2Granted
Human anti-VEGFR-2/KDR antibodies
AssigneeKadmon Corporation, LLC
InventorsDan Lu, Zhenping Zhu
Life of this patent
Estimating the term…
Abstract
The invention relates to antibodies that bind to VEGFR-2. The antibodies are used for treating neoplastic diseases, hyperproliferative disorders, and angiogenic disorders and can be used alone or in combination with other agents.
Claims8
A nucleic acid encoding an antibody or antigen binding fragment thereof that binds to human VEGFR2, the antibody or antigen binding fragment thereof comprising a heavy chain variable domain, which comprises a CDR1H, a CDR2H, and a CDR3H sequence, and a light chain variable domain, which comprises a CDR1L, a CDR2L, and a CDR3L sequence wherein:
- (i) the CDR1H sequence is GFTFSWYVMG (SEQ ID NO:
- 237);
- (ii) the CDR2H sequence is SIYPQGGATSYADSVKG (SEQ ID NO:
- 238);
- (iii) the CDR3H sequence is GNYFDY (SEQ ID NO:
- 241);
- (iv) the CDR1L sequence is RASQSVSSNYFG (SEQ ID NO:
- 245);
- (v) the CDR2L sequence is GASSRAT (SEQ ID NO:
- 246);
- and
- (vi) the CDR3L sequence is QQFDSLPLT (SEQ ID NO:
- 247).
10 more elements
Dependencies are inferred from the claim text.